Bromodomain and extra-terminal (BET) inhibitors suppress super-enhancers and show cytotoxicity against multiple types of tumors. However, early clinical trials with BET inhibitors showed severe hematopoietic toxicities, highlighting the need for sensitive tumors and rational combination strategies to enhance their therapeutic potential. Here, we identified colon cancer-specific super-enhancers that were associated with multiple oncogenic pathways, including the mitogen-activated protein kinase (MAPK) signaling pathway.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rCNkph
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Nursing students' perceptions of a video-based serious game's educational value: A pilot study. Nurse Educ Today. 2017 Dec 28;...
-
In our previous work, the dichloromethane-methanol (1:1 v/v) extract, fractions and isolated compounds from Polyscias fulva stem bark showed...
-
Anaphora is a rhetorical term for the repetition of a word or phrase at the beginning of successive clauses or verses. from #AlexandrosSfa...
-
Cincinnati.com No fooling; go get your head (and neck) examined for free Cincinnati.com Thursday, get your head examined. UC Health ...
-
Background Agricultural work can expose workers to increased risk of heat strain and volume depletion due to repeated exposures to high ambi...
-
Abstract Recent updating of the World Health Organization (WHO) classification of central nervous system (CNS) tumors in 2016 demonstrates...
-
Abstract We introduce a novel diagnostic Visual Voiding Device (VVD), which has the ability to visually document urinary voiding events an...
-
San Francisco Chronicle Inside an SF 'death trap' where nearly two dozen people lived San Francisco Chronicle Soto needed wa...
-
People use alcohol for numerous reasons; peer pressure, celebration, anxiety, sadness, boredom, rebellion and insomnia are just a few. Teens...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου